21 results on '"Ribaudo, Heather J"'
Search Results
2. Polygenic Scores and Preclinical Cardiovascular Disease in Individuals With HIV: Insights From the REPRIEVE Trial
3. Associations of Muscle Density and Area With Coronary Artery Plaque and Physical Function
4. Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV
5. Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease risk
6. Prevalence and Correlates of Electrocardiographic Abnormalities in Adults With HIV: Insights From the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)
7. The Use of the Restricted Mean Survival Time as a Treatment Measure in HIV/AIDS Clinical Trial: Reanalysis of the ACTG A5257 Trial
8. Racial differences in calculated bioavailable vitamin D with vitamin D/calcium supplementation
9. Differential CD4+ cell count increase and CD4+
10. A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness
11. Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols
12. Body Composition, Soluble Markers of Inflammation, and Bone Mineral Density in Antiretroviral Therapy–Naive HIV-1–Infected Individuals
13. Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection
14. Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants
15. Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings
16. Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure
17. Comparative Effectiveness of Initial Antiretroviral Therapy Regimens
18. Racial Differences in Virologic Failure Associated With Adherence and Quality of Life on Efavirenz-Containing Regimens for Initial HIV Therapy
19. Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression
20. Metabolic Effects of Protease Inhibitor-Sparing Antiretroviral Regimens Given as Initial Treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095)
21. Considerations in choosing a primary endpoint that measures durability of virological suppression in an antiretroviral trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.